SKIN · SkinHealth Systems Inc.
$0.64
-0.06 (-7.89%)
At close · Jul 29
Market Cap
$83.40M
Shares
129.60M
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
Program Authorized
$300,000,000
as of 2023-09-12
· total across 2 concurrent programs
Remaining Authorization
$69,800,000
as of 2025-03-31
Program Utilization
76.7%
$230,200,000 used of $300,000,000
Concurrent Repurchase Programs
| Authorized | As of | Remaining | Remaining as of | Source |
|---|---|---|---|---|
| $100,000,000 | 2023-09-12 | — | — | 10-K, filed 2026-03-12 |
| $200,000,000 | 2022-11-09 | — | — | 10-K, filed 2026-03-12 |
Cash spent on buybacks by quarter
Cash deployed each quarter. Δ marks quarters derived from the company's cumulative year-to-date disclosures.
Repurchase History
| Fiscal Year Ended | Cash Spent | Source |
|---|---|---|
| 2025-12-31 | $0 | 10-K, filed 2026-03-12 |
| 2024-12-31 | $0 | 10-K, filed 2026-03-12 |
| 2023-12-31 | $30,155,000 | 10-K, filed 2026-03-12 |
| 2022-12-31 | $160,000,000 | 10-K, filed 2025-03-12 |
| 2021-12-31 | $0 | 10-K, filed 2024-03-12 |
| 2020-12-31 | $154,000 | 10-K, filed 2023-03-01 |
| 2019-12-31 | $0 | 10-K, filed 2022-03-01 |
Key facts
CIK
1818093
CUSIP
88331L108
13F (30d)
21 filings
20 filers
Visit website
Investor relations